Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > I'm shaking my head
View:
Post by beechguy on Jul 18, 2014 9:56am

I'm shaking my head

who in their right mind is selling at .20? Buyout likely coming within 60 days. The only thing I can think of is a potential financing is still looming I guess. Partners will be very easy to come by with this news. Instead of 5 or 6 years to commercialization it could be less than 18 months. Previously a partner would have to come up with 30-50mm up front 200mm in milestones and 100m for the 2nd trial. They could buy the whole company for half that now and do some paperwork. Berendt said at the AGM that accelerated would give us 10 times more leverage with partners than without. What does no 2nd trial do then?? Smarten up sellers, you will be kicking yourself shortly! How about that US listing Dr. Berendt? Now would be pretty good timing. beech
Comment by supserstar on Jul 18, 2014 10:34am
i cant understand anybody selling for less than .65...$100 million is the minum this stock should be trading at. truthfully more like $200 million. on their corporate presentation they say this drug has $400 million global revenue potential...so if Endo gave them $25 million up front plus $125 million in milestones plus a 12% royalty plus pay for phase 3 for $50-100 million...what are all those ...more  
Comment by 13PunterDog on Jul 18, 2014 10:36am
You would have to be a total fool to sell. Health Canada to follow along with US listing. They have cash for 12-18 months. I think the Holy Grail to this stock is actually it's Chemotherapy uses. It brings back the white blood cells to normal after a few hours as I remember in dogs , don't forget that .  Berendt is a stud, that is all. GLTA Longs!!!! 13PD
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities